Par Pharmaceutical Companies Overview
- Year Founded
-
1978
- Status
-
Acquired/Merged
- Employees
-
1,900
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
17
Par Pharmaceutical Companies General Information
Description
Manufacturer of injectable products and branded drugs based in Rochester, Michingan. The company develops, manufactures and markets sterile injectables, alternative dosage forms and many other differentiated products and forming alliances with major pharmaceutical companies, specialty drug delivery companies and other product and service providers.
Contact Information
Website
www.parpharm.comCorporate Office
- One Ram Ridge Road
- NY 10977
- United States
Corporate Office
- One Ram Ridge Road
- NY 10977
- United States
Par Pharmaceutical Companies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Par Pharmaceutical Companies Comparisons
Industry
Financing
Details
Par Pharmaceutical Companies Competitors (49)
One of Par Pharmaceutical Companies’s 49 competitors is Landsteiner Scientific, a Formerly PE-Backed company based in Toluca, Mexico.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Landsteiner Scientific | Formerly PE-Backed | Toluca, Mexico | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Lannett | Corporate Backed or Acquired | Trevose, PA |
Par Pharmaceutical Companies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Par Pharmaceutical Companies Patents
Par Pharmaceutical Companies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6268356-B1 | Antitumor | Inactive | 20-Apr-1998 | ||
| US-6028065-A | As anticarcinogenic agent | Inactive | 20-Apr-1998 | ||
| US-20010048931-A1 | Oral administering | Active | 20-Apr-1998 | ||
| US-6593318-B2 | Oral administering | Inactive | 20-Apr-1998 | ||
| US-20020173497-A1 | Stability; oral administering; anticancer agents | Active | 20-Apr-1998 | A61K9/10 |
Par Pharmaceutical Companies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Par Pharmaceutical Companies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Par Pharmaceutical Companies Investments & Acquisitions (17)
Par Pharmaceutical Companies’s most recent deal was a Buyout/LBO with Ethics Bio Lab for . The deal was made on 14-Jan-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ethics Bio Lab | 14-Jan-2015 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Innoteq | 09-Jan-2015 | Buyout/LBO | Industrial Supplies and Parts | ||
| JHP Pharmaceuticals | 31-Mar-2014 | Buyout/LBO | Pharmaceuticals | ||
| Watson Pharmaceutical (14 generic products) | 16-Oct-2012 | Buyout/LBO | Buildings and Property | ||
| Handa Pharmaceuticals (Rights to Generic Dexilant) | 19-Apr-2012 | Corporate Asset Purchase | Buildings and Property |
Par Pharmaceutical Companies Exits (8)
Par Pharmaceutical Companies’s most recent exit was on 22-May-2006 from Sphere Medical Holding. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Sphere Medical Holding | 22-May-2006 | Completed |
|
||
| Optimer Pharmaceuticals | 29-Apr-2005 | Completed |
|
||
| Sphere Medical Holding | 28-Feb-2005 | Completed |
|
||
| CMR Fuel Cells | 20-Jan-2004 | Completed |
|
||
| FineTech Laboratories | 01-Jan-2002 | Merger/Acquisition | Completed |
Par Pharmaceutical Companies Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Ethics Bio Lab | Chennnai, India | 2012 |
Par Pharmaceutical Companies FAQs
-
When was Par Pharmaceutical Companies founded?
Par Pharmaceutical Companies was founded in 1978.
-
Where is Par Pharmaceutical Companies headquartered?
Par Pharmaceutical Companies is headquartered in NY.
-
What is the size of Par Pharmaceutical Companies?
Par Pharmaceutical Companies has 1,900 total employees.
-
What industry is Par Pharmaceutical Companies in?
Par Pharmaceutical Companies’s primary industry is Pharmaceuticals.
-
Is Par Pharmaceutical Companies a private or public company?
Par Pharmaceutical Companies is a Private company.
-
What is the current valuation of Par Pharmaceutical Companies?
The current valuation of Par Pharmaceutical Companies is .
-
What is Par Pharmaceutical Companies’s current revenue?
The current revenue for Par Pharmaceutical Companies is .
-
How much funding has Par Pharmaceutical Companies raised over time?
Par Pharmaceutical Companies has raised $1.46B.
-
Who are Par Pharmaceutical Companies’s investors?
Carlyle AlpInvest and TPG have invested in Par Pharmaceutical Companies.
-
Who are Par Pharmaceutical Companies’s competitors?
Landsteiner Scientific, Cipla, Novartis, Intas Pharmaceuticals, and Lannett are some of the 49 competitors of Par Pharmaceutical Companies.
-
When was Par Pharmaceutical Companies acquired?
Par Pharmaceutical Companies was acquired on 25-Sep-2015.
-
Who acquired Par Pharmaceutical Companies?
Par Pharmaceutical Companies was acquired by Endo International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
